ACTRN12612000281897招募中未知
In post menopausal women, does administration of Estradot 50mcg patches twice weekly and/or Andro-Feme cream, 1/2ml daily, for eight weeks, compared to placebo improve dry eye clinical indices and biomarkers
School of Optometry and Vision Science0 个研究点目标入组 80 人开始时间: 2012年3月9日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 50 Years 至 o limit（—）
- 性别
- Female
入选标准
- •Post menopausal women who has permanent cessation of menses for at least one year with dry eye
排除标准
- •Experience normal menstrual cycle
- •History of corneal or refractive surgery
- •Diagnosis of Sjogren’s Syndrome
- •History of hormone therapy within the past 12 months
- •Prior diagnosis of infectious disease transmittable by blood (eg HIV/AIDS, Hepatitis)
- •Eye surgery within 6 months immediately prior to enrolment for this study
研究者
相似试验
进行中（未招募）
不适用
eoadjuvant therapy for postmenopausal women with ER and/or PgR positive breast cancer. A randomized open phase II trial evaluating the efficacy of a 6 months preoperative treatment withLetrozole (2.5 mg/day) with or withoutZoledronic acid (4 mg every 4 weeks). - FEMZONEEUCTR2004-004007-37-DEovartis Pharma GmbH
进行中（未招募）
1 期
ocal Oestrogen Treatment in Postmenopausal Women Undergoing Pelvic Organ Prolapse Surgery (LOTUS)EUCTR2014-000179-18-GBniversity of Birmingham100
招募中
不适用
A randomised cross-over trial to examine the effects of calcium citrate on blood calcium levels, blood coagulation and blood pressure in normal postmenopausal womeDiet and Nutrition - Other diet and nutrition disordersCardiovascular - HypertensionCardiovascular diseaseCardiovascular - Diseases of the vasculature and circulation including the lymphatic systemACTRN12614000865617niversity of Auckland40
已完成
3 期
IBCSG IX - Adjuvant therapy in postmenopausal patients with node negative breast cancerCancer - BreastBreast CancerACTRN12607000029493International Breast Cancer Study Group900
进行中（未招募）
不适用
eoadjuvant hormone therapy for postmenopausal women with ER and/or PgR positive primary breast cancer: A multi-center study to determine the optimum length of treatment with Femara (letrozole 2.5mg daily) on tumour regression to permit breast conserving surgery.Postmenopausal women with ER and/or PgR positive primary breast cancerEUCTR2005-000661-19-GBovartis Pharmaceuticals UK Ltd